General Investing >> Money Manager Interviews >> August 26, 2016
Identifying Investments with an Opportunity for Value Creation
Daniel Lang is the Chief Investment Officer of the Value Team at RS Investments. RS Investments was acquired by Victory Capital in July 2016 and is a Victory Capital investment franchise. Dr. Lang began his investment career in 2001. Earlier, he was a portfolio manager at Farallon Capital Management covering biotech, medical device, pharma and health care services globally. Previously, he was a senior associate at venture capital firm Brilleon Capital US, and the Co-Founder and CFO of Sapient Medical Group. Dr. Lang’s 20 years of business and investment experience is preceded by a career practicing medicine. He was a clinical fellow in cardiology and a postdoctoral research fellow at the University of California, San Francisco. He was board-certified in internal medicine and was a chief medical resident at Mount Sinai Hospital in New York. He holds a B.A. in chemistry from Cornell University and an M.D. from Cornell University Medical College. Profile
TWST: Could you tell me a little bit about the fund you work on?
Dr. Lang: On the Value Team, we manage four strategies: small-cap value, midcap value, large-cap